• Urinary metabotype of severe asthma evidences decreased carnitine metabolism independent of oral corticosteroid treatment in the U-BIOPRED study 

      Reinke, Stacey N.; Naz, Shama; Chaleckis, Romanas; Gallart-Ayala, Hector; Kolmert, Johan; Kermani, Nazanin Z.; Tiotiu, Angelica; Broadhurst, David I.; Lundqvist, Anders; Olsson, Henric; Ström, Marika; Wheelock, Åsa M.; Gómez, Cristina; Ericsson, Magnus; Sousa, Ana R.; Riley, John H.; Bates, Stewart; Scholfield, James; Loza, Matthew; Baribaud, Frédéric; Bakke, Per S.; Caruso, Massimo; Chanez, Pascal; Fowler, Stephen J.; Geiser, Thomas; Howarth, Peter; Horváth, Ildikó; Krug, Norbert; Montuschi, Paolo; Behndig, Annelie; Singer, Florian; Musial, Jacek; Shaw, Dominick E.; Dahlén, Barbro; Hu, Sile; Lasky-Su, Jessica; Sterk, Peter J.; Chung, Kian Fan; Djukanovic, Ratko; Dahlén, Sven-Erik; Adcock, Ian M.; Wheelock, Craig E. (Journal article; Peer reviewed, 2022)
      Introduction Asthma is a heterogeneous disease with poorly defined phenotypes. Patients with severe asthma often receive multiple treatments including oral corticosteroids (OCS). Treatment may modify the observed metabotype, ...